Pneumococcal vaccination: information for healthcare practitioners
Information for healthcare practitioners on the changes to the infant pneumococcal vaccination schedule.
Applies to England
Documents
Details
The UK pneumococcal conjugate vaccine (PCV) immunisation programme has successfully achieved high levels of population (herd) protection for all age groups.
Currently, circulation of the 13 pneumococcal serotypes contained in the vaccine, and therefore, the risk of disease due to these serotypes, even in those at higher risk, is very low in the UK.
From 1 July 2025 the PCV13 immunisation schedule has been changed as follows:
- infants born on or after 30 June 2024 will be offered their first dose of PCV13 at 16 weeks of age to accommodate changes to routine childhood immunisation programme that move the first dose of MenB vaccine to 12 weeks
The one-year booster dose should be given regardless of the number of doses given under one year of age.
Updates to this page
-
Updated to reflect changes to the childhood immunisation schedule from 01 July 2025 with new HTML document.
-
Revised guidance and a reminder about the one-year booster dose.
-
First published.